Medical Writing Market is expected to reach US$ 9,114.91 Million by 2031

Clinical Writing Segment to Lead Medical Writing Market Based on Type During 2023–2031

According to our new research study on “Medical Writing Market Forecast to 2031 – Global Analysis – by Type, Application, and End User,” the market was valued at US$ 3,931.50 million in 2023 and is projected to reach US$ 9,114.91 million by 2031; it is expected to register a CAGR of 11.1% from 2023 to 2031. Major factors driving the market growth include the growing importance of medical writing to obtain approval from regulatory authorities and a high preference for CROs.  

Medical writing is about creating documentation and content on clinical trials, medical research, pharmaceuticals, and other health topics. Medical writing aims to present complex scientific and medical information clearly, accurately, and concisely. These documents are meant for healthcare professionals, regulatory agencies, patients, and the public. Medical writing ensures that vital medical data, research findings, and treatment information are presented well in compliance with industry standards. This certainly enriches decision-making in healthcare and improves healthcare outcomes and processes.

Medical Writing Market, by Region, 2023(%)

Source: The Insight Partners Analysis

Medical Writing Market Analysis Based on Segmental Evaluation:

Based on type, the medical writing market is categorized into clinical writing, regulatory writing, scientific writing, and others. In 2023, the clinical writing segment held a significant medical writing market share. Clinical writing is a critical element of the medical writing market, which focuses on creating and managing documentation required throughout the clinical trial process. It includes preparing essential documents such as clinical study protocols, clinical study reports (CSRs), informed consent forms, investigator brochures, and regulatory submission materials. Clinical writers collaborate closely with researchers, clinicians, and regulatory agencies to ensure clinical trial data is accurately presented and adheres to industry standards. These documents are vital for submission to regulatory bodies such as the FDA, EMA, or ICH, assisting companies in securing approvals for new drugs, treatments, and devices. The growth of the medical writing market is driven by the increasing demand for new therapies and vaccines, particularly in oncology and rare diseases.

The scope of the medical writing market report includes an assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the medical writing market share in 2023. The increasing regulatory requirements, a growing number of clinical trials, and the expanding pharmaceutical and biotech sectors are among the factors spiking the market growth in the region. Stricter compliance standards from regulatory bodies such as the United States Food and Drug Administration (US FDA) also contribute to the demand for accurate medical documentation. Additionally, the trend of outsourcing medical writing tasks is projected to accelerate the growth of the medical writing market in North America during the forecast period.  

The US holds a significant share of the medical writing market in North America. The regulatory demands, clinical trial growth, and expansion of pharmaceutical and biotech industries primarily drive the growth of the market in the country.

• Regulatory Demands: The need for precise regulatory documentation has surged due to increasing drug approvals. For instance, 55 new drugs were approved by the Center for Drug Evaluation and Research (CDER) in 2023. Medical writers play a crucial role in preparing clinical study reports, regulatory submissions, and other compliance documents.
• Clinical Trials Growth: The US is a major hub for clinical trials, particularly in oncology, rare diseases, and immunology. The growing number of trials drives the need for medical writers to support trial protocols, regulatory filings, and clinical reports.
• Pharma & Biotech Expansion: Owing to the presence of leading pharmaceutical companies such as Pfizer, Johnson & Johnson, and Merck, the US is fueling the demand for regulatory submissions, clinical trial reports, and product labeling, thereby expanding the medical writing market in the country.

IQVIA, Parexel, Syneos Health, and Covance are among the key players operating in the market. Market players adopt inorganic growth strategies for market expansion. For instance, Parexel, one of the largest clinical research organizations (CROs) in the world, offers a comprehensive range of clinical development services from Phase I to IV. They have partnered with Palantir Technologies Inc., a leader in building Artificial Intelligence (AI) systems, to create a multi-year strategic alliance aimed at enhancing and accelerating the delivery of safe and effective clinical trials for biopharmaceutical clients. Through this collaboration, Parexel will utilize Palantir’s Foundry and Artificial Intelligence Platform (AIP) to enhance its clinical data platform, focusing on increasing the efficiency of clinical trials while ensuring the highest standards of safety and regulatory compliance.

Cactus Communications, Parexel International Corp, Certara Inc., Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences are among the leading companies profiled in the medical writing market report.

Based on type, the medical writing market is categorized into clinical writing, regulatory writing, scientific writing, and others. By application, the medical writing market is segmented into medical journalism, medical education, medico marketing, and others. In terms of end user, the medical writing market is segmented into pharmaceutical and biotechnology companies and contract research organizations. Geographically, the market is categorized into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com